Share Talk LTD

Share Talk LTD

Designed for Private - Retail Investors, bloggers, brokers, PR, listed companies to communicate on one information portal. Please note we are an unregulated website and will never give out advice. We are here to make investing a level playing field.

  1. Zak Mir talks to Ippolito Cattaneo, CEO of Ajax Resources

    22 HR AGO

    Zak Mir talks to Ippolito Cattaneo, CEO of Ajax Resources

    Zak Mir talks to Ippolito Cattaneo, CEO of Ajax Resources, in the wake of recent significant news for the natural resources investment company. This includes the announcement that it has agreed to invest a total of £200,000 in Reveille Resources Limited, a European-focused investment company, intending to list on the Aquis Stock Exchange Growth Market. The investment will result in Ajax becoming a majority shareholder in Reveille. Ippolito Ingo Cattaneo, Chief Executive Officer of Ajax, commented:"We are delighted to become a major shareholder in Reveille at a formative stage in its development. The company's focus on undervalued historical mineral deposits aligns with our investment strategy, where prior exploration and infrastructure provide a strong foundation for value creation. The Lombardy Project, comprising the Novazza and Val Vedello uranium deposits, represents a compelling opportunity. These assets were the subject of extensive historical exploration, including approximately 80,000 metres of drilling, yet have not been evaluated to modern standards, offering clear potential for re-assessment and advancement. This investment is an extension of our strategy into Europe, where we see a broad pipeline of opportunities across past-producing mines with significant exploration and development potential. The evolving European energy landscape, shaped by the Russian invasion of Ukraine, ongoing geopolitical tensions in the Middle East, and the accelerating drive toward decarbonisation, has reinforced the importance of secure, domestically sourced energy. Energy autonomy is becoming an increasingly critical priority for European countries, and in this context nuclear power, and by extension uranium, is regaining strategic relevance. This is reflected in Italy, where the Government under Giorgia Meloni has signalled renewed support for nuclear energy. Against this backdrop, uranium market fundamentals and pricing have remained positive. Reveille is expected to be one of the only UK-listed, European-focused uranium exploration companies, offering investors a differentiated opportunity to gain exposure to this strategically important sector. We believe Reveille is well positioned to capitalise on these supportive macroeconomic and policy trends, and we look forward to supporting the company as it progresses towards its planned admission to the Aquis Growth Market and advances the Lombardy Project."

    20 min
  2. Powerhouse Energy CEO talks strategy and recent developments

    1 DAY AGO

    Powerhouse Energy CEO talks strategy and recent developments

    Zak Mir talks to Paul Emmitt, CEO Powerhouse Energy (AIM: PHE), as the company pioneering integrated technology that converts non-recyclable waste into low carbon energy, announced an operational update in the wake of the recent oversubscribed retail offer of £400,000 and £260,000 battery developer contract. Powerhouse Energy looks to be moving into a more commercial phase, and the most interesting part of that shift is not just about technology. It is about timing, market need and where demand is now coming from. For a long time, the story around the company was heavily tied to hydrogen and the broader net zero narrative. That is still part of the picture, especially in certain projects. But the market has evolved. The stronger angle now is decarbonisation paired with energy security, and that combination is opening doors that were not as wide open even six or twelve months ago. That is the backdrop to the latest operational progress, which follows an oversubscribed retail offer and a third-party battery developer contract worth £260,000. The bigger message is that Powerhouse is trying to prove that it is more than an early-stage technology story. It wants to show it has real engineering capability, growing commercial traction and a product that fits a changing global energy market. A step closer to commerciality One of the clearest signs of progress is the introduction of third-party work into the business. This matters because it is not simply work flowing through a historic channel or linked to an internal arrangement. It is direct business for Powerhouse itself. That may sound like a small distinction, but strategically it is important. It demonstrates that the expertise inside the company has value beyond the core waste-to-energy technology alone. In effect, the business is beginning to validate its broader engineering and technical competence in the market. That matters for two reasons: It helps bring the company forward faster by generating commercial activity now. It reinforces the core competency that will ultimately help sell the technology at scale. The company is also pushing this momentum through newer marketing activity and sales agreements in multiple regions. The effort is no longer limited to one or two flagship opportunities. It is becoming a wider commercial campaign. Why the market is changing in Powerhouse Energy’s favour The most striking theme is the shift in customer motivation. Historically, many conversations in clean technology revolved around net zero targets, emissions reduction and environmental policy. Those issues still matter, but they are now being joined, and in some cases overtaken, by a more immediate concern: security of supply. Across the world, energy markets have become more volatile. Geopolitical disruption in the Middle East, the continuing effects of the Russia-Ukraine conflict, and broader fossil fuel price instability have made businesses and governments think much harder about resilience. That is where Powerhouse sees its opportunity. If a region or business produces waste and depends on imported fossil fuels, especially diesel, then converting that waste into low carbon energy becomes about more than sustainability. It becomes a practical route to greater independence and better control over energy costs. That is a far more urgent conversation. The appeal of using local waste for local energy The company’s proposition is straightforward in principle: many regions already have a waste stream many of those same regions are exposed to expensive or insecure fuel imports turning local non-recyclable waste into energy can reduce that dependence That message appears to be resonating particularly strongly in island markets and remote locations. Places that rely heavily on diesel generation have been hit hard by rising fuel costs. Yet they also generate waste that needs dealing with. For those markets, a waste-to-energy solution addresses two problems at once: waste management energy security This is one reason why recent commercial agreements matter. The company has signed sales arrangements with Green Gecko, with HUI for Central Europe, and another covering the Caribbean islands. These are not random geographies. They line up with exactly the kind of market conditions the company believes now favour its technology. Hydrogen still matters, but it is no longer the whole story Powerhouse was originally built around a strong hydrogen focus, and that remains relevant in specific projects. The best example is Ballymena, which is expected to be the company’s flagship hydrogen development. The Ballymena project is progressing through planning, and while the pace is not as fast as management would like, the direction appears positive. There are a few notable points here: the planning process is advancing through the council system community feedback has not presented major issues the main comments received appear to relate to matters that could likely have been addressed before submission rather than fundamental opposition the next key step is receiving the Environment Agency response to the planning application Once that is in place, the company intends to apply for a permit. That permitting stage may not be quick. The project could require the first permit of its kind in Northern Ireland, which means there may be some education needed along the way. That is often the reality for businesses pioneering a newer category of infrastructure. It is not necessarily a red flag, but it does add friction and time. Still, Ballymena remains important because it would give the market a visible hydrogen-led reference project. In a company like this, proving the first flagship matters enormously. Australia could be the real game changer If Ballymena is the hydrogen flagship, Australia may be the bigger commercial catalyst. Progress there appears encouraging. The company has applied for government funding to support part of the early-stage project work, and it has brought National Waste to Energy into discussions with Green Gecko. The confidence expressed around early funding suggests management sees a realistic path to moving the project forward. The key phrase here is FID, or final investment decision. If an Australian project reaches FID, that would be a major milestone. It would represent a meaningful step from concept and development into a much more tangible commercial phase. That is why management is putting real emphasis on it. For early-stage energy and clean technology businesses, getting a project to FID can change the market’s perception of risk. It suggests that technical, financial and practical hurdles are being cleared. In that context, the Australian opportunity stands out as one of the most significant pieces of the current pipeline. 🔗 Read the full update here: https://www.share-talk.com/powerhouse-energy-ceo-talks-strategy-and-recent-developments/

    8 min
  3. Winterflood Securities, Liquidity, Retail Fundraising & the London Market Outlook

    3 DAYS AGO

    Winterflood Securities, Liquidity, Retail Fundraising & the London Market Outlook

    Zak Mir talks to Andrew Stancliffe, Head of Execution Services at Winterflood Securities, after the recent Marex takeover. They discuss the success of the Winterflood Retail Access Platform, which has now raised over £600m in fundraising and, in turn, has been a significant source of liquidity to the London stock market. Winterflood is one of those names that anyone active in UK equities will recognise from Level 2 screens, placings, and day-to-day market-making. But beyond the familiar name sits a bigger story about liquidity in small caps, how retail investors are gaining better access to fundraises, and why the UK market may be in better shape than its critics like to admit. Andrew Stancliffe, Head of Execution Services at Winterflood Securities, sits right in the middle of that story. His role covers the sales trading side of the business, working with clients ranging from institutions to retail execution brokers. Following Winterflood’s acquisition by Marex, there is also a clear focus on combining Winterflood’s market presence with Marex Financial's broader capabilities. The result is a useful window into where UK market structure is working well, where the frustrations really lie, and why technology is changing access without removing the need for human judgement. What Winterflood actually does in the market At a practical level, Winterflood sits at the heart of execution and liquidity provision in UK equities. It is a major market maker, particularly visible in smaller quoted companies, and plays an important role in helping buyers and sellers meet in names that might otherwise feel difficult to trade. Stancliffe’s remit is focused on execution services and sales trading, speaking to a broad spread of clients and helping ensure they get the best possible access to liquidity and trading opportunities. That matters because in the UK small cap market, liquidity is always the first complaint. If a share is not moving, or if trading looks thin, the market itself is usually blamed. Stancliffe’s view is more nuanced. Is there really a liquidity problem in UK small caps? Liquidity in smaller companies is one of those subjects that never seems to go away. It is a bit like the weather: people are rarely satisfied. Stancliffe’s argument is that the UK actually has one of the most vibrant and competitive small company trading environments around, especially because of the market-making infrastructure already in place. On many stocks there can be a large number of competing market makers, sometimes as many as 16, all quoting prices on screen. That creates depth which is easy to overlook. Where the challenge has become more noticeable is not necessarily in the mechanics of trading, but in the reduced participation from institutions in the smaller end of the market. Fewer institutional houses active in UK small caps naturally changes the shape of liquidity. Even so, his broader point is straightforward: if a company has a compelling story and the market cares, liquidity can appear very quickly and in significant size. That is an important distinction. Illiquidity is not always a market structure problem. Sometimes it is a company problem. Good companies tend to find liquidity One of the more refreshing parts of the discussion was the blunt acknowledgement that some shares are inactive simply because they are not interesting enough. Markets rotate. Sectors and themes move in and out of favour. Individual names can go from dormant to heavily traded once the story improves. Stancliffe used IQE as a good example. It had traded below 10p and later moved as high as 60p to 70p, accompanied by a significant jump in volume. Before that rally, liquidity may well have looked challenged. Once the market’s attention returned, so did trading activity. The lesson is simple: Liquidity can be patchy at any given moment Interesting companies tend to attract liquidity over time Strong performance often solves the liquidity complaint very quickly That is also why recent winners in the London market, including selected small caps and Aquis-listed names, have managed to generate meaningful trading interest when the underlying story has been right. Where humans still matter in an AI-driven market Electronic trading, automation and AI are now standard talking points across every part of financial markets. Execution services are no exception. Stancliffe is clearly in the camp that sees AI as a positive tool rather than a threat. His description of it as a “modern day calculator” is a good one. It captures the practical reality that AI can improve workflows, increase efficiency and help traders focus on higher-value activity, rather than replacing the core human role altogether. In execution businesses, that means automation can be used to handle smaller trades or more routine processes, while traders spend more time on larger opportunities and more complex client needs. But the key point is that relationships still matter. Markets are built on trust, communication and judgement. Those things do not disappear because technology gets better. AI may improve efficiency and service quality, but relationship building still requires human interaction, not an AI-generated email. That is probably the right balance. Technology helps scale the service. Human input still drives the important conversations. The UK government, the City and the investment culture gap with the US There has been a lot of discussion in recent years about whether governments of all colours truly understand the City, and whether policy is helping or hurting UK capital markets. Stancliffe’s take is relatively measured. He believes the current government, like its predecessors, wants to promote growth and investment. The frustration comes when policy changes create unintended consequences that weigh on the very part of the market they are trying to support. Tax changes and the treatment of AIM companies were cited as examples of where the outcome can end up being a net negative, even if the wider objective is understandable. He also highlighted a broader cultural issue. In the US, the media and the wider market ecosystem tend to celebrate investment and champion corporate success. In the UK, there is often more focus on what is going wrong. That matters because sentiment shapes participation. If the national tone around equities is too negative, it becomes harder to attract new investors, support IPOs and build confidence around domestic capital formation. Reasons for optimism on UK equities Despite the noise, Stancliffe remains optimistic about the UK market. His case rests on a few clear pillars: The UK has outstanding companies already listed There are strong private businesses that may yet come to market for growth capital The UK still has world-class universities and talent The market has delivered better performance than many people give it credit for One striking example was Rolls-Royce. While much of the media attention remained glued to US technology winners, one of the best-performing major stocks last year was listed in London, not New York. That is a useful reminder that opportunities in UK-listed businesses do exist, even if they are often under-marketed compared with the US giants. The Winterflood Retail Access Platform and why it matters If there is one area where Winterflood has made a particularly visible contribution in recent years, it is through RAP, the Winterflood Retail Access Platform. Stancliffe is understandably proud of what has been built. In just over three years, RAP has helped raise around £600 million across roughly 130 transactions, spanning listed companies and fixed income deals. That is more than just a nice growth statistic. It represents a meaningful shift in how retail investors can participate in capital raises that were historically difficult to access. Why retail investors used to miss out Placings in UK-listed companies are often fast, especially accelerated fundraises that can be completed within hours or over a day or two. Historically, that speed worked in favour of institutions and left retail investors excluded, even where they were already shareholders. The issue was not necessarily intent. It was logistics. Retail channels were simply too slow and too fragmented to participate efficiently in many of these situations. How RAP improves access RAP is designed to digitise the process and help retail shareholders take part in what Stancliffe referred to as soft pre-emption. In simple terms, it gives existing retail investors a better opportunity to maintain exposure when a listed company raises money. The platform works by sending transaction information out efficiently through major retail investment platforms, including names such as: Hargreaves Lansdown AJ Bell Interactive Investor That creates a much more seamless route for eligible investors to be represented in placings that might otherwise pass them by. It is also a genuine step forward for market fairness. Existing shareholders should not be left out purely because the process moves quickly. How to register interest in RAP Winterflood now offers a notification service for new transactions. Those interested can register via winterflood.com under the Retail Access Platform section using an email address for alerts. That is a clear upgrade from the old model where access often depended on whether a broker happened to make contact in time. Are there minimum investment sizes? In some cases, yes. There can be minimum participation levels, although Stancliffe indicated these are often relatively modest, around £250. The exact minimum depends on the individual transaction rather than being fixed across the board. So while not every deal will look identical, the general principle is that access thresholds are usually small enough to be realistic for many retail participants. Why volatility can be good for trading firms Markets had been deal

    12 min
  4. EnSilica PLC CEO Ian Lankshear speaks to Zak Mir

    5 DAYS AGO

    EnSilica PLC CEO Ian Lankshear speaks to Zak Mir

    Zak Mir talks to Ian Lankshear, CEO of EnSilica, about the leading fabless microchipmaker, which has announced that it has entered into two landmark development contracts with a leading European satellite operator to develop two chips for its next-generation satellite network.  EnSilica has been a listed company for 4 years, and after a period of steady groundwork, the business now appears to be entering a far more commercially significant phase. The key reason is simple: space communications is no longer a futuristic sideshow. It is becoming strategic infrastructure, and specialist chip design sits right at its heart. That shift was underscored by EnSilica’s recent announcement that it has secured two landmark development contracts with a leading European satellite operator. The work covers two chips for a next-generation satellite network: one for the satellite's payload and one for the user terminal on the ground. For a fabless semiconductor company, that is not just another contract win. It is the kind of milestone that can validate years of technical investment and establish a company as a serious supplier into a rapidly expanding global market. Why 2026 could be a turning point for EnSilica After four years on the market, EnSilica is now seeing several strands come together at once. The company has spent years building capability in semiconductor design, particularly in communications and high-performance, low-power applications. What is changing now is that the market is finally demanding exactly the kind of technology it has been developing. The standout development is in the space sector. EnSilica has previously announced smaller wins, feasibility studies and early-stage projects, including work with AST SpaceMobile. But this latest contract with a European satellite operator looks more substantial. It signals that EnSilica is no longer simply participating in the sector. It is beginning to establish itself as a meaningful supplier within it. The commercial logic is compelling. Satellite systems need chips that are: Extremely low power Very high performance Cost-efficient for large-scale deployment Suitable for both space payloads and ground terminals Those requirements are technically demanding, which is precisely why they can create attractive opportunities for specialist chip designers with the right expertise and intellectual property.

    10 min
  5. Zak Mir talks to Dr Jim Millen, Non-Executive Chairman, Physiomics PLC

    29 APR

    Zak Mir talks to Dr Jim Millen, Non-Executive Chairman, Physiomics PLC

    Zak Mir talks to Dr Jim Millen, Non-Executive Chairman, Physiomics, regarding recent progress at the mathematical modelling, data science and biostatistics company, and issues regarding the forthcoming requisitioned meeting. What Physiomics actually does Physiomics is a specialised life sciences consultancy that works with companies developing new drugs. At its core, the business helps drug developers make better decisions about how they design and run studies. The company operates across two main areas. Mathematical modelling to support the design of preclinical and clinical trials, with a particular focus on oncology, though not limited to cancer treatment. Biostatistics, covering the statistical design of trials, reporting, planning, and regulatory interactions around trial outcomes. That combination matters. Drug development is expensive, time-consuming and high risk. The more rigorously a company can model likely outcomes and build trials correctly from a statistical standpoint, the better its chances of generating meaningful data and navigating the regulatory process successfully. In simple terms, Physiomics is there to help clients ask the right questions before they spend serious money answering them. Why mathematical modelling and biostatistics matter in drug development It is worth pausing on this, because companies like Physiomics can easily be misunderstood as niche technical advisers operating in the background. In reality, their work sits close to the heart of pharmaceutical decision-making. A poorly designed trial can waste years. A weak statistical framework can undermine otherwise promising results. And if preclinical and clinical plans are not thought through properly, the cost of fixing mistakes later can be enormous. That is why the company’s two-pronged offering is significant: Modelling helps shape trial design and strategy Biostatistics helps ensure studies are set up, analysed and reported in a way regulators and stakeholders can rely on For drug developers, especially in challenging therapeutic areas such as oncology, that expertise can be highly valuable. Signs the business is turning a corner One of the most important points to emerge recently is that Physiomics appears to be at a positive inflection point. The company has reported its highest-ever first-half income, up by around 50% on the comparable prior period. Market expectations are also for the business to deliver its highest-ever full-year income, and management has indicated that it believes the company remains on track to achieve that. That is not a trivial development. In a market where many life sciences businesses have struggled for funding and momentum, a services company tied to that ecosystem inevitably feels the pressure too. The logic is straightforward: Physiomics serves companies developing drugs If those companies are short of capital, they become more cautious about spending That pressure filters through to specialist service providers By that measure, the last few years have not been easy. Management has been candid in saying that the wider life sciences market, especially over the past five years, has created a difficult backdrop. So when stronger income figures start to come through, that is naturally seen as evidence that the business may be emerging from a tougher period. The phrase used was that the company feels like it is "turning a corner", and the recent numbers are being presented as proof of that shift. The wider market backdrop for life sciences consultancies To understand why recent progress matters, it helps to appreciate the commercial reality of a business like Physiomics. This is not a company that develops and sells its own blockbuster drug. It provides highly specialised consultancy services to clients who are themselves trying to advance drug programmes. That means demand for Physiomics' expertise is linked to confidence, budgets and capital availability across the biotech and pharma landscape. When funding conditions tighten, even capable drug developers may delay projects, reduce outsourced work or scale back trial activity. That can hit revenue visibility for service businesses, regardless of the quality of the service provided. Against that backdrop, a strong first-half performance and confidence in a record year carry added significance. They suggest not just resilience, but possible operational momentum. The share price has improved too, but that is not the whole story Alongside the operational improvement, Physiomics' share price has also seen a notable rebound, rising by around 66% year to date at the time of discussion. In ordinary circumstances, that would probably be taken as a clear signal that sentiment around the company is improving. But the picture is complicated by corporate governance developments, namely a requisition notice from activist shareholder Mike Whitlow. That requisition has created a situation where improving business performance is happening at the same time as a challenge to the current board. So while there may be genuine momentum in the underlying business, there is also uncertainty about who should be steering it. What the requisition notice means The requisition notice would, if passed, replace the current board with a new board. Management’s position is clear: it does not believe that outcome would be in the best interests of the company. The immediate practical consequence is that shareholders have been asked to vote at a general meeting. The chairman’s strongest message on this point is simple and democratic: shareholders should vote. Whatever position an investor takes, the emphasis is on participation. This is being framed not as a routine procedural matter, but as a genuinely consequential decision about the company’s future direction and governance. That is an important distinction. Boardroom disputes can sometimes appear remote or technical. Here, the argument is that the vote could materially affect how the company is run at a delicate stage in its development. Why management says this is the wrong time to “rock the boat” The timing is at the centre of the board’s response. The current leadership’s view is that this challenge is arriving just as the company is beginning to show evidence of a turnaround. In other words, if the business is finally moving towards stronger revenue and a better trajectory, this may be precisely the wrong moment to disrupt leadership and strategy. That argument rests on a few connected ideas: The company appears to be improving operationally Recent results suggest traction rather than stagnation Change at board level introduces uncertainty Uncertainty can be especially damaging when a business is at a sensitive inflection point The phrase “rock the boat” captures the concern neatly. A business that has spent years navigating a difficult market and is now seeing signs of recovery may not benefit from abrupt upheaval, particularly if the alternative leadership has not set out a clear and credible plan. The board’s objections to the proposed replacement directors Management’s opposition is not based only on timing. It has also raised several specific concerns about the individuals named in the requisition notice. 1. Lack of clearly relevant life sciences services experience One criticism is that the proposed directors do not appear, from the current board’s perspective, to have the right experience in life sciences services. That point matters because Physiomics operates in a specialist technical area. This is not a generic consultancy business. It works at the intersection of mathematical modelling, clinical development and biostatistics. Running such a company effectively may require sector-specific understanding, not just general boardroom experience. 2. No clear plan has been presented Another issue is the lack of an articulated strategy. The current board says it has seen no evidence of a plan, not even at a high level, explaining what the replacement board would actually do with the company. That absence of detail is central to the concern. Replacing a board is one thing. Explaining the strategy that would follow is another. Without that second piece, shareholders are effectively being asked to back change without a roadmap. 3. Concerns about independence The board has also highlighted governance concerns. Specifically, it says the proposed individuals are all connected parties in some way, either through previous or current working relationships. From a governance standpoint, that raises the question of board independence. Best practice generally favours having independent directors who can challenge each other, think autonomously and avoid groupthink. If all proposed appointees are closely connected, the argument is that this could weaken the balance and independence expected of a well-run board. The central problem: shareholders are being asked to choose without enough detail Perhaps the most striking concern is also the simplest one: nobody really knows what the incoming group would do if it took control. That uncertainty sits at the heart of management’s case against the requisition. The issue is not merely whether change is good or bad in principle. It is whether shareholders should support a board replacement when the intended strategy has not been laid out. As framed by the current leadership, that creates an asymmetrical choice: Option one: keep the existing board in place while the business appears to be improving Option two: replace the board with a group that has not communicated a clear plan From that perspective, the proposed change looks less like a defined alternative and more like a leap into the unknown. That is really the essence of the argument. Could the new group still have good intentions? To be fair, the current board has not claimed that the requisitioning group intends to damage the company. In fact, the stated hope is that they are inter

    7 min
  6. Zak Mir talks to Ignacio Mehech, CEO of CleanTech Lithium

    27 APR

    Zak Mir talks to Ignacio Mehech, CEO of CleanTech Lithium

    Zak Mir talks to Ignacio Mehech, CEO of CleanTech Lithium (AIM: CTL), regarding the milestones achieved by the exploration and development company advancing sustainable lithium projects in Chile. The company recently announced an update on two trials being undertaken in North America and in Santiago, Chile, to produce battery-grade lithium carbonate from the Laguna Verde project. The trials focus on replicating and validating the process design defined in the Laguna Verde Pre-Feasibility Study. Highlights:·    In North America, stage two of the downstream processing of eluate* (see footnote for definition) produced by our DLE pilot plant located in Chile, into battery grade lithium carbonate has commenced. ·    The first stage of this work was undertaken by Conductive Energy and reported to the market in January 2025. ·    Conductive Energy was acquired by Empower EIT over the course of 2025, with Empower establishing an advanced lithium processing facility in Dallas, USA. ·    This second stage of eluate conversion will process >60m3 of concentrated eluate at the new facility. ·    The nanofiltration stage of the process will utilise an advanced membrane developed by DuPont Water Solutions to maximise impurity removal and lithium recovery. ·    Approximately 300kg of battery grade lithium carbonate are expected to be produced in Q2 2026 and made available to potential strategic partners for product qualification. ·    Concurrently, a smaller scale pilot programme is underway utilising the pilot plant of Lanshen Technology ("Lanshen"), located in Santiago, Chile. ·    This pilot plant replicates the process flowsheet developed with Lanshen for the Laguna Verde PFS and aims to demonstrate the robustness of the process design and provide a high degree of validation of the process parameters used in the PFS. ·    A volume of 24m3 of feed brine from Laguna Verde is being processed into >5kg of battery grade lithium carbonate. Ignacio Mehech, Chief Executive Officer, CleanTech Lithium said: "We are undertaking important pilot scale process trials in North America and Chile to produce battery grade lithium carbonate from Laguna Verde brine. This work will provide strong technical support for the process flow sheet used in our PFS which we think is an important consideration for engaging with potential strategic investors."

    10 min
  7. Zak Mir talks to Sath Ganesarajah, CEO of Bluebird Mining Ventures Ltd

    29 MAR

    Zak Mir talks to Sath Ganesarajah, CEO of Bluebird Mining Ventures Ltd

    Zak Mir talks to Sath Ganesarajah, CEO of Bluebird Mining Ventures Ltd (BMV), as the gold streaming, mining and treasury company confirmed that Frank Amato and Hernán M. Yellati have been appointed to the Board as Non-Executive Directors with immediate effect. Frank Amato will serve as Chair of the Audit Committee, while Hernán M. Yellati has been appointed Chair of the Remuneration and Nomination Committee. Bluebird Mining Ventures Ltd has strengthened its board with the appointment of Frank Amato and Hernán M. Yellati as Non-Executive Directors, in a move aimed at enhancing governance and strategic oversight. Amato will also serve as Chair of the Audit Committee, while Yellati takes on the role of Chair of the Remuneration and Nomination Committee. In addition, Board Advisors Darron Giddens and John Webb will participate in Audit Committee meetings, with Webb also appointed to chair a newly established Conflicts Committee. The changes are designed to bolster the company’s governance framework as it continues to execute its growth strategy. Sath Ganesarajah, Chief Executive Officer of BMV, said: "We are delighted to formally welcome Frank and Hernán to the Board. They bring significant experience across financial markets, macroeconomic strategy and emerging technologies, which will be invaluable as we continue to execute our growth strategy. "I look forward to working closely with them and our Advisory Board to further strengthen governance, enhance strategic oversight and drive the business forward. Their leadership of the Audit Committee and the Remuneration and Nomination Committee respectively will play an important role in supporting the Company's long-term objectives and delivering value for shareholders." About Bluebird Mining Ventures LtdBluebird Mining Ventures (LSE: BMV) is a gold streaming, mining and treasury company. The Company's mission is to build and manage a gold-backed treasury through streaming agreements, providing investors with exposure to physical gold without the operational risk of mining. BMV focuses on streams from producing assets within the ore concentrate to bullion value chain. Its investments secure multi-year flows of gold that can be recycled into new transactions. This model enables scalable exposure to gold without capital expenditure, or execution risks.  Drawing on its heritage in gold, BMV combines the stability of physical bullion with the benefits of a scalable, disciplined business model. With a focus on prudent capital allocation and treasury management, BMV aims to deliver sustainable, long-term value for shareholders. For more information, please visit: www.bmvbtc.com

    8 min

Ratings & Reviews

3.4
out of 5
16 Ratings

About

Designed for Private - Retail Investors, bloggers, brokers, PR, listed companies to communicate on one information portal. Please note we are an unregulated website and will never give out advice. We are here to make investing a level playing field.

You Might Also Like